Department of Psychiatry & Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, United States of America; Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, GA, United States of America; Atlanta VA Medical Center, Decatur, GA, United States of America.
Department of Psychiatry, University of South Alabama College of Medicine, United States of America; Department of Psychiatry and Health Behavior, Medical College of Georgia at Augusta University, United States of America.
J Affect Disord. 2024 Nov 1;364:249-258. doi: 10.1016/j.jad.2024.08.050. Epub 2024 Aug 13.
Dissociative symptoms are both a pathological consequence of exposure to psychological trauma as well as a side effect of N-methyl-d-aspartate (NMDA) receptor antagonist medications; therefore, accurate and valid assessment of these symptoms is important. The psychometric properties of the 23-item Clinician Administered Dissociative States Scale (CADSS) have been characterized in the ketamine and esketamine literatures. Here, we examine its performance in a sample with and without posttraumatic stress disorder (PTSD) and a history of exposure to psychological trauma.
Participants with a history of psychological trauma with (N = 148) and without (N = 100) the diagnosis of PTSD and healthy participants without a psychiatric disorder or history of trauma (N = 28) were assessed with the 23-item CADSS and other psychometric and neuropsychological assessments. Analyses were performed to examine internal consistency, convergent and discriminant validity, factor structure, differential performance in populations reported to be more or less likely to report dissociative symptoms (e.g., patients with and without PTSD), and sensitivity to change resulting from exposure to trauma-related sights and sounds.
The 23-item CADSS was found to have high internal consistency (Cronbach's alpha 0.91) and a single-factor structure. CADSS total scores in trauma-exposed participants with PTSD were higher than those in trauma-exposed participants without PTSD and non-traumatized non-PTSD participants. Finally, veterans with Iraq combat-related PTSD showed a significant increase in CADSS total score after exposure to combat-related slides and sounds.
The 23-item CADSS, already validated as a tool to measure dissociation related to administration of NMDA receptor antagonist medication, performs in a reliable and valid manner in the assessment of dissociation in psychologically traumatized participants.
分离症状既是暴露于心理创伤的病理性后果,也是 N-甲基-D-天冬氨酸(NMDA)受体拮抗剂药物的副作用;因此,准确和有效的评估这些症状非常重要。23 项临床管理分离状态量表(CADSS)的心理计量学特性已在氯胺酮和 Esketamine 文献中得到描述。在这里,我们在有和没有创伤后应激障碍(PTSD)病史以及有和没有心理创伤暴露史的样本中检查其性能。
有心理创伤史的参与者(N=148)和无 PTSD 病史的参与者(N=100)以及无精神障碍或创伤史的健康参与者(N=28)接受了 23 项 CADSS 和其他心理计量学和神经心理学评估。进行分析以检查内部一致性、收敛和判别有效性、因子结构、在据报道更有可能或不太可能报告分离症状的人群中的差异表现(例如,有和没有 PTSD 的患者)以及对与创伤相关的视觉和听觉暴露的变化的敏感性。
发现 23 项 CADSS 具有较高的内部一致性(Cronbach's alpha 0.91)和单一因素结构。有 PTSD 的心理创伤暴露参与者的 CADSS 总分高于无 PTSD 的心理创伤暴露参与者和非创伤非 PTSD 参与者。最后,患有伊拉克战斗相关 PTSD 的退伍军人在接触与战斗相关的幻灯片和声音后,CADSS 总分显着增加。
23 项 CADSS 已经过验证,可作为衡量 NMDA 受体拮抗剂药物给药相关分离的工具,在对心理创伤参与者的分离评估中以可靠和有效的方式表现。